Use of Albumin Polymers during
Breast Cancer Surgery Improves
Postoperative Seroma Outcome
Evangelos Athanassiou, M.D., Ph.D.(1)
Assistant Professor of Surgery
Nikolaos Vamvakopoulos, Ph.D.(2)
Professor of Biology
Fani Nakopoulou, M.D.(3)
Radiologist
Ioannis Fezoulidis, M.D.(3)
Professor of Radiology
Dimitrios Zaharoulis, M.D.(1)
Assistant professor of Surgery
Michael Spyridakis, M.D.(1)
General Surgeon
Constantinos Hatzitheofilou, M.D.(1)
Professor of Surgery
Departments of Surgery(1), Radiology(3), and Biology & Genetics(2),
University of Thessalia Medical School, Larisa, Greece
The effect of an albumin polymer instillation (Bioglue®; Cryolife, Inc., Kenneaw, GA, USA) during breast cancer surgery on postoperative seroma formation was evaluated. Two groups of 34 consecutive patients, treated during operation with and without polymer, were followed postoperatively by weekly ultrasound and clinical evaluation. Seroma was aspirated when the volume exceeded 250 mL. Statistical comparison between 33 of the patients with adhesive- and 32 with non-adhesive-treated patients showed that the former patient group clearly outperformed the latter in production (p<0.001) and duration (p<0.01) of seroma. Seroma outcome depended on body mass index (BMI) (>30 & <30, p<0.007), not on patient age (p<0.240) or nodes ratio (p<0.613). Repeated aspirations were made in 37.5% non-polymer treated- and 21.21% polymer-treated patients. The findings demonstrated that use of albumin polymers during breast cancer surgery lowers postoperative seroma outcome significantly.